Target intelligence / Profile preview

Neuronal membrane-associated signaling and synaptic proteins

Molecular classification
Receptor, Ion channel, Enzyme, Transporter, Other
01

Overview

Neuronal membrane-associated signaling and synaptic proteins refers to a broad and heterogeneous collection of proteins located at the neuronal plasma membrane, particularly concentrated within the synaptic cleft and the postsynaptic density (PSD). This category includes essential molecular components such as ionotropic and metabotropic neurotransmitter receptors, voltage-gated ion channels, cell adhesion molecules, and intracellular scaffolding proteins (Sheng & Kim, 2011, Cold Spring Harb Perspect Biol). These proteins are fundamental to the process of synaptic transmission, enabling neurons to communicate and undergo the plastic changes necessary for learning and memory (Bayer & Schulman, 2019, Nat Rev Neurosci). Dysregulation or loss of these proteins is a central feature of "synaptopathies," which include neurodegenerative conditions like Alzheimer's disease and psychiatric disorders such as schizophrenia and autism (Lepeta et al., 2016, J Neurochem). While many individual members of this group, such as the NMDA receptor or acetylcholinesterase, are successful therapeutic targets for drugs like memantine and donepezil, the term itself describes a functional proteome rather than a single target (Bayés et al., 2011, Nat Neurosci). Consequently, targeting this broad class requires high specificity to avoid disrupting the delicate balance of global neuronal signaling.

Other names
Synaptic proteomePostsynaptic density proteinsNeuronal membrane proteinsSynaptic signaling complex
02

Mechanism of action

Modulation of synaptic transmission through various mechanisms including receptor antagonism, ion channel block, and enzyme inhibition.

03

Biological functions

Signal transductionSynaptic plasticityNeurotransmissionCell-cell adhesion
04

Disease associations

Neurodegenerative diseaseNeuropsychiatric disordersEpilepsyOther
05

Safety considerations

Global neurological side effectsSeizure riskCognitive impairmentOff-target synaptic disruption
06

Interacting drugs

Memantine

4 more in the full profile.

07

Biomarkers

Synaptophysin (SYP)Postsynaptic density protein 95 (PSD-95)Synaptosomal-associated protein 25 (SNAP-25)Neurogranin

Beyond the preview

Go deeper on Neuronal membrane-associated signaling and synaptic proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal membrane-associated signaling and synaptic proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call